Epigenetic drug-sensitive biomarkers for cancer

Researchers perform an epigenome-wide multi-omic high-throughput screen to identify actionable epigenetic drug-sensitive biomarkers.

JD Vance’s rhetoric, and record, on the opioid epidemic

JD Vance says he’s grown all too accustomed to hearing a certain phrase when his family calls to catch him up on life in small-town

July 18, 2024

Unanimous Thumbs-Up From FDA Advisors for Alzheimer’s Drug

An FDA advisory committee on Monday unanimously supported the investigational drug donanemab for treating early Alzheimer’s disease. In an 11-0 vote, the Peripheral and Central

June 11, 2024

CMS proposes pathway to earlier breakthrough device coverage

Dive Brief: The Centers for Medicare and Medicaid Services on Thursday proposed a new reimbursement process to improve patient access to emerging medical technologies while

June 23, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.